Cook takes AAA (abdominal aortic aneurysm) graft to the US:
This article was originally published in Clinica
Executive Summary
The US FDA has given Cook the all-clear to sell its Zenith endovascular graft system for treating abdominal aortic aneurysm (AAA). The third-generation device, claims the firm, has already captured "major market share positions" in Europe, Australia and elsewhere in more than 35 other countries where it has been available commercially for several years. US sales are expected to start immediately. Advanced features of the Zenith system include suprarenal fixation and a graft design that allows treatment of a wide variety of patient anatomies, adds the Bloomington, Indiana firm.